【摘 要】
:
Targeting tubulin in rapidly dividing tumor cells is a sound strategy for cancer therapy.Despite recent advances in this field,identification of both potent and selective antimitotic molecules affecti
【机 构】
:
Institute of Developmental Biology RAS Russia
【出 处】
:
中国上海第七届国际新药发明科技年会
论文部分内容阅读
Targeting tubulin in rapidly dividing tumor cells is a sound strategy for cancer therapy.Despite recent advances in this field,identification of both potent and selective antimitotic molecules affecting tubulin/microtubule structure and dynamics is a convoluted multi-stage procedure.We have devised a "one-pot" phenotypic in vivo assay for the rapid evaluation of tubulin inhibitors using the sea urchin embryo model.The proposed procedure involves i) fertilized egg test for mitotic alteration/arrest and ii) behavioral assessment of a free-swimming blastulae.Changes of the embryo swimming pattern,i.e.rapid embryo spinning instead of forward movement,indicate the tubulin destabilizing activity caused by a test article.The assay is highly reproducible yielding rapid information on antiproliferative,antimitotic,cytotoxic,and tubulin destabilizing activities of the molecules along with their solubility and permeability potential.Using the method we identified several novel diverse tubulin destabilizing compounds with effective concentrations in nanomolar range.Measured potencies of tubulin destabilizers correlated well with the values in both purified tubulin polymerization and cell-based assays.A combination of the sea urchin embryo assay with the tests on cultured human tumor cells allowed for the rapid identification and SAR study of promising and specific tubulin inhibitors from different chemical classes.
其他文献
Hepatitis C virus infection remains a major medical problem with approximately 200 million people world wide living with the disease.The current standard of therapy is based on α-interferon (Peg-Intro
Despite the introduction and use of newer antifungal agents such as voriconazole,posaconazole and the echinocandins there is an urgent requirement for new classes of antifungals working through novel
HIV-1 infection begins with the binding of envelope glycoprotein surface subunit 120 to CD4 and a co-receptor CXCR4 or CCR5,triggering a series of conformational changes in the Env transmembrane subun
Several series of indole and azaindole derivatives,derived from the screening lead 1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione (BMS-216),were characterized as inhibitors of HIV-1.The
The monoclonal antibody (mAb) D32.10 generated by HCV particles recognizes a discontinuous epitope encompassing three regions E1 (aa297-306),E2A(aa480-494) and E2B(aa613-621) juxtaposed on the surface
The high prevalence of hepatitis C virus (HCV) infection and limited treatment options provide an opportunity to develop new therapeutics.The HCV NS3/4A serine protease is an essential enzyme for the
Kinome,which refers to the entire kinase groups in an organism,is composed of over 500 different kinases.Extracellular stimuli transmit signals into a cell by activating their target kinases.Several k
The insulin-like growth factor/IGF/signaling system plays an important role in the regulation of cell proliferation in many tissues.The IGF system is comprised ofIGF ligands,cell surface receptors/IGF
Pancreatic cancer is one of the most lethal forms of human cancer.The current first-line treatment is based on Gemcitabine,a nucleoside drug,which is only moderately effective,yielding merely a 12% re
1.The multidrug resistance phenomenon (MDR) impairs drug efficiency,leading to chemotherapeutic failure and hence causing a strong impact on disease outcome and patient survival.MDR can be mediated by